The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients

February 12, 2014 updated by: Nicholas Cepeda, York University

The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients: A Randomized Controlled Trial

The main purpose of this study is to determine the degree to which Mindfulness-Based Stress Reduction, a group-based psychological therapy that includes mindfulness meditation exercises, reduces depression, anxiety, stress, pain intensity, and interference of pain with daily life among adult chronic pain patients.

The second purpose is to examine the role of attention in improving psychological and physical health for chronic pain patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Toronto, Ontario, Canada, M5G 1X5
        • Mount Sinai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult chronic pain patients who are proficient in English
  • Capable of interacting with others in a group setting
  • Capable of working with a computer

Exclusion Criteria:

  • Alcohol or drug abuse (past history is acceptable as long as their situation has been stable for at least 3 months)
  • Psychiatric psychosis (patients who have a past history of schizophrenia are eligible as long as they are currently stable)
  • Current major depressive disorder
  • Current severe social phobia
  • At immediate risk for suicide
  • Cerebral lesions or tumors (unless medically and cognitively stable)
  • Neurological disease
  • Medically unstable
  • Cognitively unstable
  • Previously participated in a mindfulness meditation program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Waitlist Control
Active Comparator: Mindfulness-Based Stress Reduction
Behavioral: Mindfulness-Based Stress Reduction
An 8-week structured group program that was developed to improve psychological and physical symptoms associated with pain. It incorporates a variety of mindfulness meditation exercises including mindful yoga, sitting meditation, and body scan to facilitate attention, acceptance, and awareness of one's experiences.
Other Names:
  • MBSR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain disability and Attention
Time Frame: Baseline, immediately following treatment, and at 3 months follow up

Change in pain disability assessed by the Pain Disability Index (PDI).

Change in attention assessed by an adapted version of the Change Blindness Task
Baseline, immediately following treatment, and at 3 months follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in depression assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Baseline, immediately following treatment, and at 3 months follow up
Anxiety
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in anxiety assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Baseline, immediately following treatment, and at 3 months follow up
Stress
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in stress assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)
Baseline, immediately following treatment, and at 3 months follow up
Mindfulness
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ) and Mindful Attention Awareness Scale (MAAS)
Baseline, immediately following treatment, and at 3 months follow up
Acceptance
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in acceptance assessed by the Chronic Pain Acceptance Questionnaire (CPAQ)
Baseline, immediately following treatment, and at 3 months follow up
Pain Intensity
Time Frame: Baseline, immediately following treatment, and at 3 months follow up
Change in pain intensity assessed by the Short-form McGill Pain Questionnaire (SF-MPQ-2).
Baseline, immediately following treatment, and at 3 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

York University

Collaborators

Mount Sinai Hospital, Canada
Wasser Pain Management Centre
Rasch Foundation

Investigators

  • Principal Investigator: Allan Gordon, MD, Mount Sinai Hospital
  • Principal Investigator: Nicholas Cepeda, PhD, York University
  • Study Director: Denise Paneduro, PhD student, York University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

November 1, 2013

Study Registration Dates

First Submitted

December 5, 2011

First Submitted That Met QC Criteria

December 5, 2011

First Posted (Estimate)

December 7, 2011

Study Record Updates

Last Update Posted (Estimate)

February 13, 2014

Last Update Submitted That Met QC Criteria

February 12, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FWA00003852

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Mindfulness-Based Stress Reduction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe